QQ客服 官方微博 反馈留言

	Immunoglobulin G for patients with necrotising soft tissue infection (INSTINCT): a randomised, blinded, placebo-controlled trial
	Madsen, Martin B. ; Hjortrup, Peter B. ; Hansen, Marco B. ; Lange, Theis ; Norrby-Teglund, Anna ; Hyldegaard, Ole ; Perner, Anders
	2017
关键词	Fournier&apos Necrotising fasciitis Patient-reported outcome measure Quality of life Sepsis SF-36 A STREPTOCOCCAL INFECTIONS TOXIC-SHOCK-SYNDROME INTRAVENOUS IMMUNOGLOBULIN SEPTIC SHOCK CLINICAL-TRIAL HYDROXYETHYL STARCH SEVERE SEPSIS THERAPY MANAGEMENT CARE s gangrene
英文摘要	Purpose: The aim of the INSTINCT trial was to assess the effect of intravenous polyspecific immunoglobulin G (IVIG) compared with placebo on self-reported physical function in intensive care unit (ICU) patients with necrotising soft tissue infection (NSTI). Methods: We randomised 100 patients with NSTI 1:1 to masked infusion of 25 g of IVIG (Privigen, CSL Behring) or an equal volume of 0.9% saline once daily for the first 3 days of ICU admission. The primary outcome was the physical component summary (PCS) score of the 36-item short form health survey (SF-36) 6 months after randomisation; patients who had died were given the lowest possible score (zero). Results: Of the 100 patients randomised, 87 were included in the intention-to-treat analysis of the PCS score, 42 patients (84%) in the IVIG group and 45 patients (90%) in the placebo group. The two intervention groups had similar baseline characteristics with the exception of IVIG use before randomisation (1 dose was allowed) and rates of acute kidney injury. Median PCS scores were 36 (interquartile range 0-43) in the group assigned to IVIG and 31 (0-47) in the group assigned to placebo (mean adjusted difference 1 (95% confidence interval -7 to 10), p = 0.81). The result was supported by analyses adjusted for baseline prognostics, those in the per protocol populations, in the subgroups (site of NSTI) and those done post hoc adjusted for IVIG use before randomisation. Conclusions: In ICU patients with NSTI, we observed no apparent effects of adjuvant IVIG on self-reported physical functioning at 6 months.; CSL Behring; European Union's Seventh Framework Programme [NCT01790698]; Fresenius Kabi, Germany; Ferring Pharmaceuticals, Denmark; SCI(E); ARTICLE; 11; 1585-1593; 43
语种	英语
出处	SCI
出版者	INTENSIVE CARE MEDICINE
内容类型	其他
源URL	[http://hdl.handle.net/20.500.11897/484581]
专题	数学科学学院
推荐引用方式 GB/T 7714	Madsen, Martin B.,Hjortrup, Peter B.,Hansen, Marco B.,et al. Immunoglobulin G for patients with necrotising soft tissue infection (INSTINCT): a randomised, blinded, placebo-controlled trial. 2017-01-01.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。